共 12 条
- [1] Jonsson B(2019)Advanced therapy medicinal products and health technology assessment principles and practices for value-based and sustainable healthcare Eur J Health Econ 20 427-438
- [2] Drummond MF(2019)Analytic considerations in applying a general economic evaluation reference case to gene therapy Value Health 22 661-668
- [3] Garrison LP(2019)Value-based pricing for emerging gene therapies: the economic case for a higher cost-effectiveness threshold J Manag Care Spec Pharm 25 793-799
- [4] Hettle R(2017)The assessment and appraisal of regenerative medicines and cell therapy products: an exploration of methods for review, economic evaluation and appraisal Health Technol Assess 21 1-204
- [5] Hanna E(2016)Advanced therapy medicinal products: current and future perspectives J Mark Access Health Policy 6 33-218, xvii
- [6] Theidel U(2016)Benefit assessment in Germany: implications for price discounts Health Econ Rev 17 1-12
- [7] von der Schulenburg JM(2015)Market access pathways for cell therapies in France J Mark Access Health Policy 9 5-undefined
- [8] Remuzat C(2015)France: health system review Health Syst Transit undefined undefined-undefined
- [9] Chevreul K(2017)New criteria of Italian Medicine Agency for the attribution of therapeutic innovation: viewpoint of the pharmacologist Giornale Italiano di Farmacoeconomia e Farmacoutilizzazione undefined undefined-undefined
- [10] Scavone C(undefined)undefined undefined undefined undefined-undefined